Undulatoside A has shown potential in anti-inflammatory applications due to its ability to inhibit key inflammatory mediators such as nitric oxide and prostaglandin E2 in cellular models. It has been studied for its effects on suppressing pro-inflammatory cytokine production, suggesting possible use in developing treatments for chronic inflammatory conditions. Additionally, preliminary research indicates neuroprotective properties, making it a candidate for further investigation in neurodegenerative disease research. Its natural origin and structural complexity also make it a subject of interest in drug discovery for targeting specific cellular pathways involved in inflammation and oxidative stress.